Reza Bahrami | Neonatology | Best Researcher Award

Posted on by Best Paper Award

Dr. Reza Bahrami | Neonatology | Best Researcher Award

Associate Professor at Shiraz University of Medical Sciences, Iran

Dr. Reza Bahrami is an Assistant Professor of Neonatology at Shiraz University of Medical Sciences, Iran. He earned his M.D. from Shiraz University of Medical Sciences in 1997, followed by a Pediatric Residency at Kerman University of Medical Sciences and a Neonatology Fellowship at Shiraz University. With extensive experience in neonatal intensive care, he has been leading the NICU at Zaynabieh Hospital since 2011.

Dr. Bahrami’s research focuses on neonatology, pediatric genetics, metabolic disorders, and the impact of infectious diseases, including COVID-19, on vulnerable populations. He has authored numerous publications in high-impact journals, particularly in neonatal health, genetic disorders, and epidemiological studies. His most cited work includes studies on vertical transmission of COVID-19, genetic predisposition to obesity and cleft lip, and the impact of metabolic diseases on COVID-19 outcomes.

Beyond research, Dr. Bahrami is actively involved in medical education, mentoring medical students, pediatric residents, and neonatology fellows. His contributions to neonatal care and pediatric medicine continue to shape clinical practice and research in Iran and beyond.

Publication Profile

Scopus

Google Scholar

Orcid

Educational Details

Dr. Reza Bahrami obtained his M.D. from Shiraz University of Medical Sciences, Iran, in 1997. He completed his Pediatric Residency at Kerman University of Medical Sciences in 2007 and earned his Neonatology Fellowship from Shiraz University of Medical Sciences in 2011. He also holds board certifications in Pediatrics (2007) and Neonatology (2011) from the Iranian National Board of Medical Examinations.

Professional Experience

Dr. Bahrami began his academic career as an Assistant Professor in the Department of Pediatrics at Fasa University of Medical Sciences (2007-2009). Since 2011, he has been an Assistant Professor in the Department of Neonatology at Shiraz University of Medical Sciences. He currently serves as the Chief of the Neonatal Intensive Care Unit (NICU) at Zaynabieh Hospital. His role involves providing specialized neonatal care, mentoring medical students, pediatric residents, and neonatology fellows, and supervising clinical research projects.

Research Interest

Dr. Bahrami’s research focuses on neonatology, neonatal screening, hemoglobinopathies, neonatal sepsis, and alternative therapies for neonatal care. He has conducted studies on neonatal anemia screening, the impact of herbal medicine on infant health, and the immunogenicity of vaccines in neonates.

Top Noted Publication

Vertical Transmission of Coronavirus Disease 2019 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review

  • Journal: Fetal and Pediatric Pathology (2020)
  • Citations: 637
  • Summary: This review examines the potential for SARS-CoV-2 transmission from pregnant mothers to their newborns, analyzing case studies and discussing clinical implications for neonatal care.

Proportion and Mortality of Iranian Diabetes Mellitus, Chronic Kidney Disease, Hypertension, and Cardiovascular Disease Patients with COVID-19: A Meta-Analysis

  • Journal: Journal of Diabetes & Metabolic Disorders (2021)
  • Citations: 46
  • Summary: This meta-analysis evaluates the prevalence and mortality risk of COVID-19 among Iranian patients with preexisting metabolic and cardiovascular diseases.

The Risk and Prevalence of COVID-19 Infection in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

  • Journal: Journal of Gastrointestinal Cancer (2020)
  • Citations: 36
  • Summary: This study investigates the susceptibility of colorectal cancer patients to COVID-19 and assesses potential complications due to the infection.

Evidence from a Meta-Analysis for Association of MC4R rs17782313 and FTO rs9939609 Polymorphisms with Susceptibility to Obesity in Children

  • Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews (2021)
  • Citations: 34
  • Summary: A genetic study exploring the role of specific polymorphisms in childhood obesity, contributing to the understanding of genetic predispositions to metabolic disorders.

Association of BMP4 rs17563 Polymorphism with Nonsyndromic Cleft Lip with or Without Cleft Palate Risk: Literature Review and Comprehensive Meta-Analysis

  • Journal: Fetal and Pediatric Pathology (2021)
  • Citations: 34
  • Summary: This meta-analysis examines the genetic link between BMP4 polymorphisms and the risk of nonsyndromic cleft lip and cleft palate, contributing to pediatric and genetic research.

Conclusion

Dr. Reza Bahrami is a highly suitable candidate for the Best Researcher Award in Neonatology due to his significant contributions to neonatal health, highly cited research, leadership in neonatal intensive care, and commitment to medical education. Strengthening international collaborations, exploring novel neonatal treatments, and publishing in top-tier journals could further enhance his research impact.

Sidharth Mahapatra | Pediatrics | Best Researcher Award

Posted on by Best Paper Award

Mr. Sidharth Mahapatra | Pediatrics | Best Researcher Award

Associate Professor at University of Nebraska Medical Center – UNMC, United States

Dr. Sidharth Mahapatra is a physician-scientist specializing in pediatric critical care medicine and pediatric neuro-oncology. He serves as an Associate Professor at the University of Nebraska Medical Center and Creighton University School of Medicine, where he directs research in the Division of Critical Care Medicine. His research explores molecular pathways in pediatric brain tumors and respiratory distress syndromes, with a strong focus on developing novel targeted therapies. Dr. Mahapatra has received numerous awards for clinical excellence, research innovation, and medical education, including the Hobart E. Wiltse Excellence in Medical Education Award (2023), the NCI Loan Repayment Award (2022), and multiple UNeMed Invention Contributor recognitions.

Publication Profile

scopus

Google Scholar

orcid

Educational Details

Dr. Sidharth Mahapatra earned his B.A. in Cellular/Molecular Biology from Knox College, Galesburg, IL, graduating Magna Cum Laude with an Honors Thesis under Mark R. Brodl. He pursued his M.D. and Ph.D. in Biochemistry/Molecular Biology at Rosalind Franklin University, North Chicago, IL, where he was inducted into Alpha Omega Alpha and conducted his Ph.D. research under Kenneth E. Neet.

Professional Experience

Dr. Mahapatra is an Associate Professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center (UNMC), Omaha, NE. He also holds a faculty position as an Assistant Professor in Biomedical Sciences at Creighton University School of Medicine. Previously, he was an Assistant Professor in Pediatrics and Biochemistry & Molecular Biology at UNMC and Creighton University.

In addition to his academic roles, Dr. Mahapatra has been the Director for Research in the Division of Critical Care Medicine at UNMC since 2021, having previously served as Interim Director (2018–2020).

Research Interest

Dr. Mahapatra’s research focuses on pediatric neuro-oncology, medulloblastoma, and critical care medicine, particularly in pediatric acute respiratory distress syndrome (PARDS). His work involves the molecular mechanisms of tumor progression and metastasis, with a special interest in identifying novel therapeutic targets for pediatric brain tumors and other malignancies.

Author Metrics

Dr. Mahapatra has authored numerous high-impact publications, with a growing citation record in pediatric critical care and cancer research. Some of his notable publications include:

  • “Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE)” – The Lancet Respiratory Medicine (2019) – 327 citations
  • “Acute respiratory distress syndrome” – StatPearls [Internet] (2024) – 138 citations
  • “MUC4 mucin—a therapeutic target for pancreatic ductal adenocarcinoma” – Expert Opinion on Therapeutic Targets (2017) – 85 citations
  • “Disruption of C1galt1 gene promotes development and metastasis of pancreatic adenocarcinomas in mice” – Gastroenterology (2018) – 82 citations
  • “microRNAs orchestrate pathophysiology of breast cancer brain metastasis: advances in therapy” – Molecular Cancer (2020) – 64 citations

Top Noted Publication

1. Paediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE): An International, Observational Study

  • Authors: RG Khemani, L Smith, YM Lopez-Fernandez, J Kwok, R Morzov, MJ Klein, et al.
  • Journal: The Lancet Respiratory Medicine
  • Volume/Issue: 7(2), Pages 115-128
  • Year: 2019
  • Citations: 327
  • DOI: 10.1016/S2213-2600(18)30344-8
  • Summary: This international observational study examines the incidence and epidemiology of pediatric acute respiratory distress syndrome (pARDS). It provides insights into global variability, risk factors, and outcomes associated with pARDS in critically ill children.

2. Acute Respiratory Distress Syndrome

  • Authors: M Diamond, HL Peniston, DK Sanghavi, S Mahapatra
  • Journal: StatPearls [Internet]
  • Year: 2024
  • Citations: 138
  • Access: Available on StatPearls database
  • Summary: This review provides an updated understanding of acute respiratory distress syndrome (ARDS), covering its pathophysiology, clinical presentation, diagnostic criteria, and therapeutic approaches. It is a valuable reference for clinicians and researchers.

3. MUC4 Mucin—A Therapeutic Target for Pancreatic Ductal Adenocarcinoma

  • Authors: SK Gautam, S Kumar, A Cannon, B Hall, R Bhatia, MW Nasser, et al.
  • Journal: Expert Opinion on Therapeutic Targets
  • Volume/Issue: 21(7), Pages 657-669
  • Year: 2017
  • Citations: 85
  • DOI: 10.1080/14728222.2017.1337772
  • Summary: This paper explores MUC4 mucin as a potential therapeutic target for pancreatic ductal adenocarcinoma (PDAC). It highlights the role of MUC4 in tumor progression, metastasis, and chemoresistance, emphasizing its potential as a novel treatment target.

4. Disruption of C1galt1 Gene Promotes Development and Metastasis of Pancreatic Adenocarcinomas in Mice

  • Authors: S Chugh, S Barkeer, S Rachagani, RK Nimmakayala, N Perumal, et al.
  • Journal: Gastroenterology
  • Volume/Issue: 155(5), Pages 1608-1624
  • Year: 2018
  • Citations: 82
  • DOI: 10.1053/j.gastro.2018.07.013
  • Summary: This study investigates the role of the C1galt1 gene in pancreatic adenocarcinoma. The authors demonstrate that its disruption accelerates tumor progression and metastasis in mouse models, suggesting its potential as a biomarker or therapeutic target.

5. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy

  • Authors: RK Kanchan, JA Siddiqui, S Mahapatra, SK Batra, MW Nasser
  • Journal: Molecular Cancer
  • Volume: 19, Pages 1-16
  • Year: 2020
  • Citations: 64
  • DOI: 10.1186/s12943-020-01161-5
  • Summary: This review discusses the role of microRNAs in breast cancer brain metastases, emphasizing their involvement in tumor progression, invasion, and therapeutic resistance. The paper explores emerging miRNA-based treatment strategies.

Conclusion

Dr. Sidharth Mahapatra is a highly suitable candidate for the Best Researcher Award due to his exceptional contributions to pediatric critical care and neuro-oncology. His leadership, impactful publications, and clinical-research integration make him a strong contender. Addressing the areas for improvement, such as securing larger grants and increasing first-author publications, could further elevate his candidacy.